医学
技术
乳房密度
乳房成像
乳腺摄影术
层析合成
数字乳腺摄影术
乳腺X光筛查
放射科
入射(几何)
乳腺癌
核医学
乳腺癌筛查
神秘的
分子成像
错误发现率
肿瘤科
乳腺组织
临床试验
内科学
作者
Carrie B. Hruska,Katie N. Hunt,Nicholas B. Larson,Patricia A. Miller,Richard L. Ellis,Robin B. Shermis,Gaiane M. Rauch,Amy Lynn Conners,Jeannette Gasal Spilde,D. Semaan,Emily C. Siegal,Shannon N. Zingula,Sabala Mandava,Tamara S. Martin,Riffat K. Ahmed,Dana H. Whaley,Beatriz E. Adrada,Lacey R. Gray,Ramila A. Mehta,Rebecca J Roll
出处
期刊:Radiology
[Radiological Society of North America]
日期:2025-09-01
卷期号:316 (3): e243953-e243953
被引量:9
标识
DOI:10.1148/radiol.243953
摘要
= .048). The year 1 recall rate was 8.6% (255 of 2978 participants) with DBT and 17.9% (534 of 2978 participants) with DBT plus prevalence screening MBI (difference, 9.4% [95% CI: 8.4, 10.5]). The year 2 recall rate was 8.9% (231 of 2590 participants) with DBT and 13.8% (356 of 2590 participants) with DBT plus incidence screening MBI (difference, 4.8% [95% CI: 4.1, 5.7]). Twenty-nine participants had cancers detected only with MBI: 21 (72%) had invasive cancers (median size, 0.9 cm), 26 (90%) had node-negative cancers, and six (20%) had advanced cancers. The interval cancer rate was 0.7‰ (two of 2978 participants) in year 1 and 0.8‰ (two of 2590 participants) in year 2. Conclusion The addition of MBI to DBT screening increased invasive cancer detection by 2.5-fold and modestly increased the recall rate at the second screening round. © RSNA, 2025 See also the editorial by Fowler in this issue.
科研通智能强力驱动
Strongly Powered by AbleSci AI